Exclusive dermatology updates brought to you by the Journal of Drugs in Dermatology (JDD) online editorial team. Stay up-to-date on dermatology and aesthetic news, conference coverage, featured articles and more.
JDD Online News
Harness the Power of AGE Inhibition for Superior Post-Resurfacing Results A breakthrough split-face study shows that a targeted AGE-inhibitory moisturizer dramatically elevates post-resurfacing skincare outcomes for all skin tones. After…
Uncovering Hidden Autoimmune Threats In Healed Zoster Sites Sometimes the skin that’s healed from herpes zoster can harbor an unexpected surprise. In two striking cases, patients developed new autoimmune eruptions—discoid…
Zabalafin’s All-In-One Assault On Inflammation, Infection, Dryness, and Itch Atopic dermatitis has long been driven by a vicious circle—staph overgrowth, immune flare-ups, parched skin, and relentless itch that feed one…
Check out our all-new JDD Video Abstract from Gary S. Rogers, MD, who discusses Placental Allograft Reconstruction of Cutaneous Wounds Following Mohs Surgery: A Propensity Score-Matched Comparative Cost-Effectiveness Analysis.
Why CBD’s Skin-Deep Potential Is Both Promising—And Puzzling For Your Practice Over the past decade, CBD has gone from a niche curiosity to a bona fide buzzword in skincare. Acting…
Curated by the JDD Editors Missed any of our August highlights? August is our psoriasis issue–a must-read. Catch up with this curated roundup from the JDD Editors—your guide to must-read articles…
Check Out JDD Corner’s Latest Author Spotlight Our latest Author Spotlight shines on Mark G. Lebwohl, MD, co-author of “Resolving Hyperkeratotic Psoriasis: Mechanisms of Action and Additive Effects of Fixed-Combination…
Recent Safety and Efficacy Data for Biologics in Psoriasis Treatment options for plaque psoriasis have proliferated significantly in the past decade, with an influx of biologics. With these seemingly interchangeable options,…
Welcome to our exclusive webinar, where we invite you to explore the intersection of beauty and science with Neutrogena®, a leader in the skincare industry. Join us as we delve…
A New Outreach Program Demonstrates How Targeted Education Can Transform Access To Dermatologic Care Since its launch in 2020, DermmunityTM, a community service program run by the USC Department of…
A Concise Look at the IMMPulse Trial Comparing Apremilast And Risankizumab In Moderate Plaque Psoriasis In a compelling video interview for the Journal of Drugs in Dermatology, Dr. Christopher Bunick…
Several media outlets covered an August Journal of Drugs in Dermatology survey on the perceived dermatologic side effects of cancer treatments and how those perceptions could impact a person’s decision…
As the most common inflammatory skin disease, Acne Vulgaris is unavoidable in our line of work. By default, we have to be Princes/Princesses of Pimples, though fortunately we have a…
Oatmeal Uncovered: Your New Ally in Skin Health Discover why colloidal oatmeal has earned its spot in modern dermatology. At the JDD Oats in Skincare Educational Resource Center, we’ve assembled…
Transforming Routine Visits into Early‐Warning Systems for Psoriatic Arthritis What if every psoriasis appointment could double as a stealth screening for psoriatic arthritis? In one of our latest JDD articles titled…
Rice Bran Reimagined: A New Frontier in Hair Health Could this ancient grain extract be the next go-to for patients battling
Rethinking Spironolactone Dosing in Female Pattern Hair Loss Could a lower dose of spironolactone offer relief to women struggling with thinning hair? Female pattern hair loss (FPHL) is a multifactorial condition…
Elevate your practice with the very latest clinical insights, case studies, and CME, all in one place. Discover the Acne Resource Center - your new go-to microsite for the very…
Check out our all-new JDD Video Abstract from Christopher G. Bunick, who discusses PDE4 Inhibitors: Bridging Molecular Insights With Clinical Impact.
Boosting Psoriasis Outcomes with a Dual Strategy - Deucravacitinib Plus Calcipotriene/Betamethasone Foam Shows Lasting Benefits A promising new open-label study in our August issue highlights how adding topical calcipotriene/betamethasone dipropionate…
Scar Therapy Showdown—Triamcinolone Takes the Crown, but the Field Is Full of Contenders Are you reassessing your approach to hypertrophic and keloid scars? A PRISMA-guided review in the August 2025…
Listen Now! If you’ve been snoozing on the latest JDD "Ask the Investigator" podcast episodes, consider this your wake-up call! Hosted by the ever-insightful Dr. Adam Friedman and sponsored by…
Living with dandruff can be uncomfortable and frustrating. Join board-certified dermatologist Dr. Natasha Mesinkovska to learn about effective dandruff management strategies and discover CeraVe’s new, dermatologist-developed haircare system. Dr. Mesinkovska…
Case Reports Are Now Unlocked Access—Your Next Dermatology Obsession Is Just One Click Away! Did you know that the latest Case Reports in JDD are unlocked for everyone—and from here on…
Living with dandruff can be uncomfortable and frustrating for the 52 million Americans who have the condition. Join Dandruff affects 52 million Americans. Join Dr. Houshmand’s review of clinical data…
Catch Up on the Latest Think about the last time you saw real-world data reshape your treatment approach—what if you discovered that one of our most trusted biologics behaves differently…
Living with dandruff can be uncomfortable and frustrating for the 52 million Americans who have the condition. Join Dandruff affects 52 million Americans. Join Dr. Houshmand’s review of clinical data…
Check Out Our Latest TSLS The field of dermatology continues to evolve at a rapid pace, bringing groundbreaking research from the lab to the clinic. As part of its ongoing…
Living with dandruff can be uncomfortable and frustrating. Join board-certified dermatologist Dr. Natasha Mesinkovska to learn about effective dandruff management strategies and discover CeraVe's new, dermatologist-developed haircare system. Dr. Mesinkovska…
Did You Miss These? Missed any of our recent Video Abstracts? Catch up now! A Scientific Approach to Defining, Evaluating, and Treating Pre-Aging With a Cosmetic Regimen Containing a…
Botulinum Toxin for Hidradenitis Suppurativa? Early Evidence Looks Promising Hidradenitis suppurativa (HS) remains a challenging and often painful condition—one that disproportionately affects women, people of color, and underserved populations. With…
Author Spotlight: Dr. Natalia Neha Khosla on Health Equity, Inflammation, and Innovation in Dermatology July’s JDD Author Spotlight features Natalia Neha Khosla, MD MSc, author of the July article, “Socioeconomic…
A Closer Look at Alopecia Areata in Black Patients: Are We Missing Key Diagnostic Clues? Alopecia areata (AA) is more prevalent in patients with skin of color —but how well…
Why Visible Light Protection Matters—Especially for Your Patients with Melasma and Deeper Skin Tones Sun protection isn’t just about UV rays anymore. Visible light, making up nearly half the sunlight…
Can Probiotics Help Psoriasis? This Study Says Yes—And Here’s Why You Should Pay Attention Could your next psoriasis treatment plan include probiotics? A randomized, double-blind, placebo-controlled trial published in JDD’s June…
Join Dr. Pearl Grimes, MD and Dr. Hawasatu Dumbuya, PhD, for an informative and interactive webinar on new research advances in broad-spectrum and visible light photoprotection needs and strategies for…
From the Vault: The Heterogeneity of Atopic Dermatitis Atopic dermatitis (AD) isn’t a single-symptom disease, and treating it like one may shortchange your patients. A focused review in a JDD…
Pregnancy-Related Pyoderma Gangrenosum: Misdiagnosed, Understudied, and Clinically Challenging A new systematic review sheds light on the rare but serious occurrence of pyoderma gangrenosum (PG) during pregnancy and the postpartum period,…
Lip Augmentation with HA Fillers: Anatomy, Technique, and Safety Essentials Pulling from the JDD vault, let’s revisit this January 2023 article. As demand for lip augmentation still grows, dermatologists are…
Hyperpigmentation Patients Report Low Satisfaction and Limited Awareness of Treatment Options A new cross-sectional survey reveals that hyperpigmentation, especially among patients with deeper skin tones, continues to be a significantly…
Curated by the JDD Editors Missed any of our July highlights? As the official partner of the Skin of Color Update , July is our “Bridging the Gap in Dermatology”…
Biologics for Mastocytosis? New Evidence Supports Targeted Treatment Success Could the next breakthrough for mastocytosis already be in your therapeutic toolbox? A new article in the July issue of JDD…
July Is Hyperpigmentation & Melasma Awareness Month – Did You Know We Have a Curated Resource Just for You? As summer sun peaks, so does your patients' concern about dark…
Test Your Knowledge! Join Dr. Alexis Carrington, Chief Dermatology Resident at George Washington University, to help understand dermatologic conditions across all skin tones. Decoding Derm: What’s the Diagnosis is a…
Lotion or Cream? A Fresh Look at Moisturizer Efficacy in Dry Skin Dry skin is more than just a nuisance, it’s a clinical challenge that affects comfort, barrier function, and,…
Catch Up on July’s Latest Case Report on Pincer Nail Relief Pincer nail deformity isn’t just unsightly, it’s painful, persistent, and notoriously difficult to treat. While braces and surgery are…
Not Just Cosmetic: Dermatologic Procedures as Gender-Affirming Care Botox, fillers, microneedling—these are often labeled “cosmetic,” but for many transgender patients, they serve a far deeper purpose. This article in the July…
July Article Spotlight In parts of the world where red clay soil coats the ground, podoconiosis—non-filarial elephantiasis—continues to devastate lives. This neglected tropical disease affects nearly 4 million people globally…
Beyond Minoxidil: Is It Time to Rethink Female Hair Loss Treatment? More than half of postmenopausal women, and a significant percentage of younger, healthy women, struggle with visible hair loss,…
Access Inequity in Atopic Dermatitis Care: Are Your Patients Getting Left Behind? Gentle skin care is a foundation of atopic dermatitis (AD) treatment, but what happens when patients can’t afford,…
June 25 marks World Vitiligo Day, a global recognition of a condition that affects approximately 0.5-2% of the population worldwide. Though non-life-threatening, vitiligo carries a profound psychosocial burden, disproportionately affecting…
Neoadjuvant Hedgehog Inhibitors: Gaining Ground in Mohs for BCC? A recent survey of American College of Mohs Surgery members reveals that 22% of Mohs surgeons are already using hedgehog pathway…
Researchers at NYU Langone Health and the Perlmutter Cancer Center have discovered why many patients with melanoma are resistant to current treatments and how an existing drug class is effective…
Healio profiled a new universal classification system for topical corticosteroids that could reduce confusion across countries. The system was published in the May Journal of Drugs in Dermatology in an…
Active ingredients play a critical role in the efficacy and safety of cosmeceuticals. Join Jill Waibel, MD as she shares information on the efficacy and safety of cosmeceutical formulations, highlighting…
Featured Video Abstract Check out our all new video abstract from Cheri Frey, MD, where she discusses a scientific approach to defining, evaluating, and treating pre-aging with a cosmetic regimen…
Topical Trouble Spots: Treating Hyperkeratotic Plaques with Confidence Hyperkeratotic psoriatic plaques, those dense, elevated, and heavily scaled lesions, can be particularly resistant to topical therapy. A new post hoc analysis…
Curated Hair Content: Just For You! Scarring alopecia remains a challenging and often emotionally devastating diagnosis for patients. With its potential for permanent hair loss and the frequently delayed path to…
From the Vault: Chasing the “Benjamin Button” Effect - The Art and Economics of Noninvasive Rejuvenation Inspired by the film character who ages in reverse, the so-called “Benjamin Button” effect…
Could an Eczema Treatment Also Protect the Heart? Looking at Upadacitinib and Cardiovascular Risk Atopic dermatitis (AD) may start on the skin, but its impact goes much deeper. As a…
Taming the Flare: A Practical Algorithm for Managing Atopic Dermatitis with or without Infection For patients with atopic dermatitis (AD), flares aren’t just a passing inconvenience, they can be emotionally…
Acne Awareness Month: Spotlight on Innovation, Impact, and Individualized Care June is Acne Awareness Month, a timely reminder that acne vulgaris is more than a rite of passage—it’s a complex, chronic…
If Benzoyl Peroxide Disappears: What’s Next for Acne Treatment? Benzoyl peroxide (BPO) has long been a staple in acne therapy—widely used, well-understood, and highly effective. But its future on the…
Mind the Data Gap: Treating Acne-Induced Hyperpigmentation in Deep Skin Tones Acne-induced macular hyperpigmentation (AMH) is a persistent and distressing concern for many patients with richly melanated skin, particularly those…
Could a Migraine Medication Clear Cystic Acne? A Curious Case Suggests New Possibilities What if a drug you prescribe for migraines could also help treat cystic acne? A recent JDD…
Has TikTok Helped Your Patients Recognize Hidradenitis Suppurativa Sooner? You might have heard it from your own patients: “I saw a video on TikTok and realized I might have HS.”…
Is Your Patient’s Gut Making Their Skin More Sensitive to the Sun? Drug-induced photosensitivity is nothing new, but could the gut microbiome be influencing how severely patients react to sunlight?…
From Molecule to Medicine: Why Roflumilast Is Raising the Bar for Topical PDE4 Inhibitors Phosphodiesterase-4 (PDE4) inhibitors are having a moment, and if you’re not yet familiar with the molecular…
GLP-1RAs and Isotretinoin: A Risky Combination? Recent reports on dermatologic side effects of GLP-1 receptor agonists (GLP-1RAs) have prompted a closer look at how these drugs interact with other treatments,…
JDD From the Vault: Estrogen Deficient Skin: A Topical Option for Postmenopausal Facial Aging Have you seen this one? We’re highlighting a frequently visited JDD article from the vault that…
"Clean," "Natural," "Cruelty-Free": Why Your Patients Are Asking—and What You Need to Know With the rise of “clean beauty,” more patients are coming to dermatology visits with questions about the…
Time for a Global Standard? Rethinking Topical Corticosteroid Classification Topical corticosteroids (TCS) are a mainstay in dermatology, used to treat a wide range of skin conditions. While effective and generally…
Photodynamic Therapy for Actinic Keratosis: Can We Make It Painless? Actinic keratosis (AK), a common result of sun damage, can be a warning sign for squamous cell carcinoma. With skin…
What Happens After Isotretinoin? New Insights Into Post-Treatment Acne Care Isotretinoin remains the gold standard for treating severe acne, but relapse after treatment is common, affecting 20 to 60% of…
The Hidden Role of C. acnes in Dandruff: Beyond the Flakes Dandruff affects nearly 50% of the global population, yet its exact causes remain under ongoing investigation. While most clinicians…
Isotretinoin Dosing in Adolescents: Does Weight Change Matter? Isotretinoin remains the gold standard for treating severe nodulocystic acne, with cumulative dosing of 120-150 mg/kg shown to balance safety and efficacy. Higher…
Upadacitinib may provide additional health benefits, including reducing the risk of major adverse cardiovascular events (MACE) and venous thromboembolism (VTE). That’s according to a May Journal of Drugs in Dermatology…
Faster Relief for Seborrheic Dermatitis? A Case for Topical Roflumilast Seborrheic dermatitis is a chronic inflammatory skin condition that often frustrates patients and clinicians alike, especially during flare-ups. While topical corticosteroids…
By Allison Sit A new American Academy of Dermatology (AAD) survey shows American adults may not fully understand the benefits of sunscreen. The survey of 1,000 adults found nearly one…
What Skin Toxicities May Signal in Melanoma Patients on Immunotherapy Cutaneous immune-related adverse events (irCAEs) are among the most common side effects seen in patients receiving immune checkpoint inhibitors (ICIs)…
Test Your Knowledge! Join Dr. Alexis Carrington, Chief Dermatology Resident at George Washington University, to help understand dermatologic conditions across all skin tones. Decoding Derm: What’s the Diagnosis is a…
Painless™ PDT vs. Conventional PDT: A Quick Look at Patient Comfort in AK Treatment Actinic keratosis (AK) is one of the most common conditions treated by dermatologists, and photodynamic therapy…
Melanoma Education on Instagram: What’s Missing—Especially for Skin of Color As melanoma rates rise, with a projected 7.3% increase in new cases and 3.8% rise in mortality in 2024, the…
What to Expect When Treating SCC In Situ with Mohs Surgery While squamous cell carcinoma in situ (SCCIS) is typically considered a low-risk skin cancer, treatment decisions, especially around surgical…
EMPSGC: Why Mohs Might Be the Better Choice Endocrine Mucin Producing Sweat Gland Carcinoma (EMPSGC) is rare, low-grade, and slow-growing—but it’s not without risk. Though uncommon, recurrence and even distant…
This webinar delves into the emerging field of dermatoporosis, a chronic skin fragility condition. Participants will explore the latest translational research that bridges basic science and clinical practice, enhancing our…
From the Vault As more patients turn to the internet for guidance on pregnancy-safe skincare, dermatologists are increasingly fielding questions about what’s safe to use during pregnancy. One JDD article,…
Could Proteasome Inhibitors Offer a New Option for Pressure Injuries? Pressure injuries, especially in the sacral area, are a frequent and frustrating challenge, particularly in elderly patients. Standard care focuses…
In acknowledgement of National Melonoma and Skin Cancer Awareness Month, we are rerunning this series of Decoding Derm. Join Dr. Alexis Carrington in Decoding Dermatology: What’s the Diagnosis, as she presents a…
Knowledge is Critical for Successful Outcomes: Current Landscape of Hyaluronic Acid Filler Use in the United States When a recent article of Allure recently explored the science behind “medical-grade”…
WATCH NOW: Racial and Ethnic Representation in Atopic Dermatitis Clinical Trials With content flying at us from every direction, it’s easy to miss what matters most. That’s why JDD Corner…
Melanoma Mortality Drops Where Dermatologists Are in High Supply: Read the Data New data shows a powerful link: the more dermatologists in your area, the lower your risk of dying…
Just put some salve on it" sounds so innocuous one could follow up with, "what could possibly go wrong?" Never ask that. Yes, our skin is our living breathing barrier…
Cylindrocarcinoma: Could Mohs Surgery Be the Clear-Cut Winner? Cylindrocarcinoma—a rare malignant offshoot of benign cylindromas—poses a surgical challenge due to its potential for recurrence and metastasis. While traditional excision has…
Explore JDDonline If you’re on the hunt for expert-led, handpicked resources on psoriasis, you’re in the right place. Whether you're brushing up on the latest treatment insights or looking for…
A Fern with Far-Reaching Potential: The Role of Polypodium Leucotomos Extract in Dermatology From photoaging to pigmentary disorders, Polypodium leucotomos extract (PLE)—a botanical with notable photoprotective and anti-inflammatory properties—has emerged…
Did you miss it? By 2044, people with skin of color (SOC) will make up the majority of the U.S. population—but dermatology still lags behind in addressing their unique needs.…
Acne Treatment Without the Dry-Out: Clascoterone Cream 1% Proves Gentle on the Skin Barrier Topical acne meds often come with an unfortunate side effect: dry, irritated skin that leaves patients…
Active ingredients play a critical role in the efficacy and safety of cosmeceuticals. Join Dr. Corey L. Hartman, as he shares information on a new cosmeceutical formulation. This presentation will…
April Issue Must-Read! Hidradenitis suppurativa (HS) isn’t just painful—it’s deeply isolating. And new data reveals why: the majority of people living with HS don’t feel heard, treated, or informed. In a…
